Free Trial

Protagenic Therapeutics (PTIXW) Competitors

$0.0080 0.00 (0.00%)
(As of 12/20/2024 05:16 PM ET)

PTIXW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDW

Should you be buying Protagenic Therapeutics stock or one of its competitors? The main competitors of Protagenic Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

Protagenic Therapeutics vs.

Protagenic Therapeutics (NASDAQ:PTIXW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, media sentiment, valuation, community ranking and institutional ownership.

In the previous week, Protagenic Therapeutics' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Protagenic Therapeutics Neutral
180 Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
Protagenic TherapeuticsN/A N/A N/A
180 Life Sciences N/A N/A N/A

Protagenic Therapeutics and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Protagenic TherapeuticsN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Protagenic TherapeuticsN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

Protagenic Therapeutics and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Get Protagenic Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTIXW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PTIXW vs. The Competition

MetricProtagenic TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$165.68M$5.14B$9.08B
Dividend YieldN/A3.64%5.09%4.23%
P/E RatioN/A115.5190.0517.18
Price / SalesN/A18,531.021,116.25117.05
Price / CashN/A12.8743.1037.85
Price / BookN/A8.594.784.78
Net IncomeN/A-$20.67M$120.31M$225.60M
7 Day PerformanceN/A-1.05%-1.92%-1.23%
1 Month PerformanceN/A174.77%13.65%0.46%
1 Year PerformanceN/A134.18%28.34%15.24%

Protagenic Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PTIXW
Protagenic Therapeutics
N/A$0.01
flat
N/A-46.7%$0.00N/A0.002
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A+31.6%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
flat
N/A+22.1%$0.00N/A0.002
AIMDW
Ainos
N/A$0.03
flat
N/A-89.6%$0.00$40,633.000.0040News Coverage
Gap Up
ALVOW
Alvotech
N/A$2.78
+1.1%
N/A+48.5%$0.00$391.87M0.004Gap Up
ALVO
Alvotech
2.6676 of 5 stars
$12.05
+2.1%
$18.00
+49.4%
+6.9%$0.00$93.38M0.001,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/A+408.0%$0.00N/A0.004
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/AN/A$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.09
flat
N/A+340.0%$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.47
flat
N/A-56.1%$0.00$193.06M0.00N/A

Related Companies and Tools


This page (NASDAQ:PTIXW) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners